Journals / Turkish Journal of Gastroenterology / 2013 / Cilt: 24 - Sayı: 6

Kısa bağırsak sendromu olan hastalarda büyüme hormonu, glutamin ve enteral beslenmenin intestinal adaptasyon üzerindeki etkisi

Effect of growth hormone, glutamine, and enteral nutrition on intestinal adaptation in patients with short bowel syndrome

Pages
463–468
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Fo- ur weeks of intestinal rehabilitation therapy significantly improved intestinal absorption if appropriate patient with short bowel syndrome was selected.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aims: In the management of short bowel syndrome, the benefits of treatment with growth hormone, glutamine, and enteral nutrition for intestinal adaptation is still controversial.
📊
Key Findings & Data:Materials and Method: Twelve patients with short bowel syndrome (small-bowel remnant length, 59±9 cm; mean±SEM) received growth hormone (0.05 mg/kg/day), oral gluta- mine (30 g/day), plus enteral nutrition for 4 weeks.
💡
Conclusion & Impact:Conclusion: Fo- ur weeks of intestinal rehabilitation therapy significantly improved intestinal absorption if appropriate patient with short bowel syndrome was selected.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aims: In the management of short bowel syndrome, the benefits of treatment with growth hormone, glutamine, and enteral nutrition for intestinal adaptation is still controversial. The aim of the current study was to determine whether growth hor- mone, glutamine, and enteral nutrition had positive effect on intestinal adaptation. Materials and Method: Twelve patients with short bowel syndrome (small-bowel remnant length, 59±9 cm; mean±SEM) received growth hormone (0.05 mg/kg/day), oral gluta- mine (30 g/day), plus enteral nutrition for 4 weeks. Intestinal absorptive capacity and biochemical parameters were investigated before treatment and after treatment. Body composition was determined by bioelectric impedance analysis. Result: All patients completed the treatment. Intestinal absorptive capacity and plasma levels of proteins were significantly improved after treatment. Body weight, lean body mass, total body water, and body cell mass also increased without any major adverse effects. At the 3-month follow-up, the nutritional status of patients was also well maintained, and there was no death during this period. Conclusion: Fo- ur weeks of intestinal rehabilitation therapy significantly improved intestinal absorption if appropriate patient with short bowel syndrome was selected.

Özet

Giriş ve Amaç: Kısa barsak sendromunun tedavisinde, büyüme hormonunun, glutaminin ve enteral beslenmenin barsak adaptasyonuna olan etkisi halen tartışmalıdır. Bu çalışmanın amacı büyüme hormonu, glutamin ve enteral beslenmenin barsak adaptasyonuna katkısının araştırılmasıdır. Gereç ve Yöntem: Kısa barsak sendromu olan 12 hastaya (kalan ince barsak uzunluğu 59±9 cm) büyüme hormonu (0,05 mg/kg/gün), oral glutamin (30 mg/gün) ve enteral beslenme (4 hafta süre ile) uygulandı. Barsak absorbtif kapasitesi ve biyokimyasal parametreler tedaviden önce ve sonra incelendi. Vücut kompozisyonu biyoelektirik impedans yöntemi kullanılarak incelendi. Bulgular: Tüm hastalar tedaviyi tamamladı. Tedavi ertesinde barsak absorbtif kapasitesinde, plazma protein düzeylerinde belirgin düzelme kaydedildi. Hastaların kilo, kuru vücut ağırlığı, toplam vücut suyu ve hücre kütlesinde de artış kaydedildi ve ciddi yan etki tespit edilmedi. Üç aylık takipten sonra, ölüm görülmedi ve hastaların beslenme durumu iyiydi. Sonuç: iyi seçilmiş kısa barsak sendromlu hastalarda 4 haftalık rehabilitasyon uygulaması absorbtif kapasitede belirgin düzelme sağlamaktadır.

🔖

Cite This Article

GUO, M., LI, Y., LI, J. (2013). Kısa bağırsak sendromu olan hastalarda büyüme hormonu, glutamin ve enteral beslenmenin intestinal adaptasyon üzerindeki etkisi. Turkish Journal of Gastroenterology, Cilt: 24 - Sayı: 6, 463–468. https://ajindex.com/articles/409580

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. O'Keefe SJ, Buchman AL, Fishbein TM, et al. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol 2006; 4:6-10
  2. Sondheimer JM, Asturias E, Cadnapaphornchai M. Infecti- on and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroente- rol Nutr 1998; 27:131-7
  3. Burstyne M, Jensen GL. Abnormal liver functions as a re- sult of total parenteral nutrition in a patient with short-bo- wel syndrome. Nutrition 2000; 16:1090-2
  4. Terra RM, Plopper C, Waitzberg DL, et al. Remaining small bowel length: association with catheter sepsis in pa- tients receiving home total parenteral nutrition: evidence of bacterial translocation. World J Surg 2000; 24:1537-41
  5. Candusso M, Faraguna D, Sperli D, et al. Outcome and quality of life in paediatric home parenteral nutrition. Curr Opin Clin Nutr Metab Care 2002; 5:309-14
  6. Byrne TA, Persinger RL, Young LS, et al. A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann Surg 1995; 222:243- 55
  7. Scolapio JS, Camilleri M, Fleming R, et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroentero- logy 1997; 113:1074-81
  8. Jeppesen PB, Szkudlarek J, Mortensen PB. Effect of high- dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and es- sential fatty acids status in short bowel patients: a rando- mized, double-blind, crossover, placebo-controlled study. Scand J Gastroenterol 2001; 36:48-54
  9. Byrne TA, Wilmore DW, Iyer K, et al. Growth hormone, glutamine, and an optimal diet reduces parenteral nutriti- on in patients with short bowel syndrome: A prospective, randomized, placebo-controlled, double-blind clinical trial. Annals of Surgery 2005; 242:655-661
  10. Kjeldahl J. Neue Method Zur Bestimmung der stickstoffs in Organischen Korpern. Z Anal Chem 1883; 22:366-9
  11. Cummings JH, James WP, Wiggins HS. Role of the colon in ileal-resection diarrhoea. Lancet 1973; 1:344-7
  12. Buts JP, Morin CL, Ling V. Influence of dietary compo- nents on intestinal adaptation after small bowel resection in rats. Clin Invest Med 1979; 2:59-66
  13. Sukhotnik I, Hayari LL, Bashenko Y, et al. Dietary palmi- tic acid modulates intestinal re-growth after massive small bowel resection in a rat. Pediatric Surgery International 2008; 24:1313-21
  14. Byrne TA, Cox S,